[1] Zhang C. Attention should be paid to the early diagnosis and treatment of treatable neurogenetic diseases[J]. Zhonghua Shen Jing Ke Za Zhi, 2012, 45:625-629.[张成. 重视可治性神经遗传病的早期诊断和早期治疗[J]. 中华神经科杂志, 2012, 45:625-629.]
[2] Chen CY, Zhu XY, Tan XL, Zuo J. Preliminary exploration into rare disease teaching in medical genetics[J]. Ji Chu Yi Xue Yu Lin Chuang, 2015, 35:1145-1147.[陈曹逸, 朱新宇, 谭湘陵, 左伋. 医学遗传学课程教学中"罕见病"教学初探[J]. 基础医学与临床, 2015, 35:1145-1147.]
[3] Li J, Hu CH, Yu CS, Cao JQ, Yang J, Li YQ, Zhan YX, Zhang C. Long-term follow up of four patients with dopa-responsive dystonia[J]. Zhonghua Shen Jing Ke Za Zhi, 2013, 46:153-158.[利婧, 胡朝晖, 喻长顺, 操基清, 杨娟, 李亚勤, 詹益鑫, 张成. 多巴反应性肌张力障碍长期随访四例[J]. 中华神经科杂志, 2013, 46:153-158.]
[4] Zhang C, Lin JF, Liao ZY. Advance and cogitation of gene therapy for Duchenne muscular dystrophy[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2019, 19:312-319.[张成, 林金福, 廖子钰. Duchenne型肌营养不良症基因治疗进展与思考[J]. 中国现代神经疾病杂志, 2019, 19:312-319.]
[5] Li J, Zhang C. Clinical research advance of therapeutic strategies for spinal muscular atrophy[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2019, 19:385-392.[利婧, 张成. 脊髓性肌萎缩症治疗临床研究进展[J]. 中国现代神经疾病杂志, 2019, 19:385-392.]
[6] Zhang C, Lin JF. The research status and problems of Duchenne muscular dystrophy in China[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2018, 18:470-474.[张成, 林金福. 我国Duchenne型肌营养不良症研究现状及存在问题[J]. 中国现代神经疾病杂志, 2018, 18:470-474.]
[7] Zhang C, Zhu YL. The importance of early diagnosis and treatment in treatable neuromuscular diseases[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2018, 18:557-562.[张成, 朱瑜龄. 应重视可治性神经肌肉病的早期诊断与治疗[J]. 中国现代神经疾病杂志, 2018, 18:557-562.]
[8] Zhang C, Wang L. History of glycogen storage disease typeⅡ[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2018, 18:563-572.[张成, 王倞. 糖原贮积病Ⅱ型发展史[J]. 中国现代神经疾病杂志, 2018, 18:563-572.] |